Octagon Capital Advisors LP
Top Portfolio Positions
29 positions ·
$903,609,411 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
1,946,667 | $163,364,294 | 18.08% |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
2,350,000 | $90,451,500 | 10.01% |
| ABVX |
Abivax S.A.
Healthcare
|
677,000 | $75,383,950 | 8.34% |
| ALMS |
Alumis Inc.
Healthcare
|
2,830,700 | $62,360,321 | 6.90% |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
2,440,000 | $46,116,000 | 5.10% |
| AVBP |
ArriVent BioPharma, Inc.
Healthcare
|
1,971,054 | $45,472,215 | 5.03% |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
8,859,911 | $39,603,802 | 4.38% |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
425,000 | $35,398,250 | 3.92% |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
338,900 | $31,307,582 | 3.46% |
| BIOA |
BioAge Labs, Inc.
Healthcare
|
1,748,000 | $30,572,520 | 3.38% |
Portfolio Trend
Holdings in DNTH
Shares Held
Position Value (USD)
11 of 11 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $163,364,294 | 1,946,667 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $99,590,847 | 2,416,667 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $95,095,846 | 2,416,667 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $43,625,256 | 2,341,667 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $42,477,839 | 2,341,667 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $46,001,640 | 2,110,167 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $47,823,742 | 1,746,667 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $45,203,741 | 1,746,667 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $41,420,010 | 1,380,667 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,761,600 | 554,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,561,600 | 480,000 | Shares | Sole | 2023-11-14 | |
| No quarters match your search. | ||||||